The world's leading technology giants see technology in diabetes as a priority area. To achieve success, they partner with traditional ...
The world's leading technology giants see technology in diabetes as a priority area. To achieve success, they partner with traditional medical device manufacturers such as Dexcom or Sanofi.
The main reason is because they do not want to miss the opportunity to participate in the potential market with more than 100 million patients and is still growing very fast.
Current treatment regimens and procedures, such as finger blood tests and adjustments to insulin doses, have been implemented for a long time, clearly an incomplete approach.
Factors that affect blood sugar, such as diet and activity, do not have the tools to support the sick.
Verily, a subsidiary of Alphabet, formerly known as Google Life Sciences, partnered with Dexcom to provide a continuous tracking system and build a training service. The company also tried to develop contact lenses that kept track of the road, but it failed.
Amazon aims to sell tracking devices and help patients read the results with Alexa voice assistance tools.
Apple works with device manufacturers like Dexcom to connect devices with Apple Watch and iPhone.
Verily also cooperates with Sanofi to develop Onduo software to support and guide patients to lifestyle changes, diet and exercise optimization.
Ms. Phoenix
